SC
RVMD icon

Shay Capital’s Revolution Medicines RVMD Stock Holding History

Shay Capital’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34M Buy
12,500
+500
+4% +$73K 0.15% 126
2026
Q1 		$1.17M Sell
12,000
-10,260
-46% -$1.04M 0.1% 158
2025
Q4 		$1.77M Sell
22,260
-23,740
-52% -$1.56M 0.18% 124
2025
Q3 		$2.15M Buy
+46,000
New +$1.8M 0.19% 114

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Shay Capital's RVMD Position: Q2 2026 in Review

Shay Capital increased its Revolution Medicines (RVMD) stake by 4.2% in Q2 2026, buying an estimated $73K and bringing the position to 12,500 shares worth $2.34M. The position accounts for 0.15% of the portfolio, ranked #126.

Shay Capital first reported a position in RVMD in Q3 2025 and has held it in 4 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Shay Capital held 12,500 shares of Revolution Medicines worth $2.34M as of Q2 2026.
  • Shay Capital bought 500 Revolution Medicines shares in Q2 2026, an estimated $73K.
  • Revolution Medicines made up 0.15% of Shay Capital's portfolio in Q2 2026, its #126 holding.
  • Shay Capital first reported a position in Revolution Medicines in Q3 2025 and has held it in 4 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Shay Capital's 13F filing for Q2 2026, filed 14 Aug 2026.